Last reviewed · How we verify
NCT04819594
The Effects of Aromatherapy on the Stress Levels of Nurses Working in an Urban, Safety-Net Community Hospital
NA trial testing Elequil aromatabs ® in Stress Levels in 319 participants. Completed in 31 October 2021.
1 October 2021
Quick facts
| Lead sponsor | Parkland Health and Hospital System |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 319 |
| Start date | 1 June 2021 |
| Primary completion | 1 October 2021 |
| Estimated completion | 31 October 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Elequil aromatabs ®
Conditions studied
- Stress Levels — all drugs for Stress Levels →
Sponsor
Parkland Health and Hospital System
Who can join
18 and older, any sex, with Stress Levels. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Parkland Hospital inpatient nursing staff will be the focus of this study. This project aims to investigate the use of lavender on the stress levels associated with the nursing role. Nurses will wear the Elequil aromatabs ® over a four-hour period and a post survey will be given to assess root cause of stress and changes related to intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04819594
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Parkland Health and Hospital System trials
Trials by the same sponsor.
- NCT04840212 — The Effectiveness of Aromatherapy in an Urban, Safety-Net Hospital on Pain · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04819594 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Parkland Health and Hospital System
- Last refreshed: 2 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04819594.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing